ATE16799T1 - Pyrimidin-2-sulfide und ihre s-oxide zur verwendung in der medizin, die verbindungen enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und die verbindungen an sich, sofern sie neu sind. - Google Patents

Pyrimidin-2-sulfide und ihre s-oxide zur verwendung in der medizin, die verbindungen enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und die verbindungen an sich, sofern sie neu sind.

Info

Publication number
ATE16799T1
ATE16799T1 AT81300098T AT81300098T ATE16799T1 AT E16799 T1 ATE16799 T1 AT E16799T1 AT 81300098 T AT81300098 T AT 81300098T AT 81300098 T AT81300098 T AT 81300098T AT E16799 T1 ATE16799 T1 AT E16799T1
Authority
AT
Austria
Prior art keywords
group
compounds
carboxyl
esterified
hydroxy
Prior art date
Application number
AT81300098T
Other languages
English (en)
Inventor
Tore Benneche
Mikkel Josef Gacek
Kjell Undheim
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Application granted granted Critical
Publication of ATE16799T1 publication Critical patent/ATE16799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT81300098T 1980-01-10 1981-01-09 Pyrimidin-2-sulfide und ihre s-oxide zur verwendung in der medizin, die verbindungen enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und die verbindungen an sich, sofern sie neu sind. ATE16799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8000802 1980-01-10
EP81300098A EP0033195B1 (de) 1980-01-10 1981-01-09 Pyrimidin-2-sulfide und ihre S-Oxide zur Verwendung in der Medizin, die Verbindungen enthaltende pharmazeutische Zusammensetzungen, Verfahren zu ihrer Herstellung und die Verbindungen an sich, sofern sie neu sind

Publications (1)

Publication Number Publication Date
ATE16799T1 true ATE16799T1 (de) 1985-12-15

Family

ID=10510550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81300098T ATE16799T1 (de) 1980-01-10 1981-01-09 Pyrimidin-2-sulfide und ihre s-oxide zur verwendung in der medizin, die verbindungen enthaltende pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und die verbindungen an sich, sofern sie neu sind.

Country Status (12)

Country Link
US (1) US4423047A (de)
EP (1) EP0033195B1 (de)
JP (1) JPS56154467A (de)
AT (1) ATE16799T1 (de)
AU (1) AU549117B2 (de)
CA (1) CA1168240A (de)
DE (1) DE3173080D1 (de)
DK (1) DK149885B (de)
ES (2) ES8205782A1 (de)
NO (1) NO810064L (de)
NZ (1) NZ195992A (de)
ZA (1) ZA81140B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596870A (en) * 1981-01-09 1986-06-24 Nyegaard & Co. A.S. Substituted pyrimidin-2-ones and the salts thereof
EP0087326B1 (de) * 1982-02-24 1987-05-13 Nycomed As Substituierte Pyrimidin-2-one und deren Salze
JPH0739394B2 (ja) * 1985-05-30 1995-05-01 住友化学工業株式会社 含窒素複素環化合物およびそれを有効成分として含有する有害生物防除剤
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
US4808591A (en) * 1988-02-16 1989-02-28 Pfizer Inc. Antiulcer 8-(2-pyrimidylsulfinyl)quinolines
DE3912155A1 (de) * 1988-09-24 1990-03-29 Bayer Ag Schaedlingsbekaempfungsmittel auf basis von 2-halogenalkylthio-substituierten pyrimidin-derivaten
WO1991016309A1 (en) * 1990-04-12 1991-10-31 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
GB9106609D0 (en) * 1991-03-28 1991-05-15 Ici Plc Heterocyclic compounds
EP0506270A1 (de) * 1991-03-28 1992-09-30 Zeneca Limited Nematozide Pyrimidinverbindungen
EP0506269A1 (de) * 1991-03-28 1992-09-30 Zeneca Limited Nematozide Pyrimidinverbindungen
GB9219635D0 (en) * 1992-09-16 1992-10-28 Ici Plc Heterocyclic compounds
DE19622270A1 (de) * 1996-06-03 1997-12-04 Basf Ag Pyrimidin-4-carbonsäureamide
US6268310B1 (en) * 1997-01-28 2001-07-31 Nippon Soda Co., Ltd. Oxazole derivative, process for producing the same, and herbicide
CZ297264B6 (cs) 1998-09-09 2006-10-11 Metabasis Therapeutics, Inc. Nové heteroaromatické inhibitory fruktóza-1,6-bisfosfatázy
EP1144380A4 (de) * 1998-11-30 2003-11-26 Ishihara Sangyo Kaisha Meta-nitrophenol-derivat und ein verfahren zu seiner herstellung
US6313072B1 (en) * 1999-02-18 2001-11-06 American Cyanamid Company Herbicidal 2-aryloxy-or 2-arylthio-6-arylpyrimidines
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US7138404B2 (en) * 2001-05-23 2006-11-21 Hoffmann-La Roche Inc. 4-aminopyrimidine derivatives
DE10154075A1 (de) * 2001-11-02 2003-05-15 Bayer Cropscience Ag Substituierte Pyrimidine
WO2008014199A2 (en) * 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 receptor
US9364191B2 (en) 2013-02-11 2016-06-14 University Of Rochester Method and apparatus of spectral differential phase-contrast cone-beam CT and hybrid cone-beam CT
WO2015108779A1 (en) 2014-01-16 2015-07-23 E. I. Du Pont De Nemours And Company Pyrimidinyloxy benzene derivatives as herbicides
TWI828952B (zh) 2015-06-05 2024-01-11 美商艾佛艾姆希公司 作為除草劑之嘧啶氧基苯衍生物
GB201514649D0 (en) * 2015-08-18 2015-09-30 Medical Res Council 2-Sulfonylpyrimidines
EP3619206B1 (de) 2017-05-02 2024-02-14 FMC Corporation Pyrimidinyloxybenzo-kondensierte verbindungen als herbizide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3112316A (en) * 1963-11-26 Z-o-chlohobenzylmercapto-x-dimethyl-
US2876224A (en) * 1957-08-07 1959-03-03 American Home Prod Basic esters of substituted pyrimidine-4-carboxylic acids and their preparation
DE2455582A1 (de) 1974-11-23 1976-05-26 Hoechst Ag Verfahren zur herstellung von (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-sulfiden
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
US4248618A (en) * 1977-05-06 1981-02-03 Ici Australia Limited Derivatives of (pyrimidyloxy)phenoxy-alkanecarboxylic acid and herbicidal compositions thereof
NZ188244A (en) * 1977-09-13 1981-04-24 Ici Australia Ltd 2-substituted pyrimidines compositions growth regulating processes

Also Published As

Publication number Publication date
US4423047A (en) 1983-12-27
EP0033195A1 (de) 1981-08-05
EP0033195B1 (de) 1985-12-04
DE3173080D1 (en) 1986-01-16
NZ195992A (en) 1983-11-30
ES508498A0 (es) 1983-03-16
DK149885B (da) 1986-10-20
ES498406A0 (es) 1982-08-01
ES8205782A1 (es) 1982-08-01
DK8081A (da) 1981-07-11
CA1168240A (en) 1984-05-29
ZA81140B (en) 1982-02-24
JPS56154467A (en) 1981-11-30
ES8304947A1 (es) 1983-03-16
NO810064L (no) 1981-07-13
AU6613081A (en) 1981-07-16
AU549117B2 (en) 1986-01-16

Similar Documents

Publication Publication Date Title
AU549117B2 (en) Pyrimidine-2-sulphides and their 5-oxides
ATE19513T1 (de) Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE132144T1 (de) Chalkonderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
PT65019B (de) Phenylalkancarbonsaure-derivate und verfahren zu ihrer herstellung
IL64647A0 (en) Trisubstituted pyrimido(5,4-d)pyrimidines,their preparation and pharmaceutical compositions containing them
ATE21693T1 (de) Substituierte pyrimid-2-one, ihre salze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
ES8308559A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ATE19874T1 (de) Delta 8,9-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES483247A1 (es) Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos
ATE22284T1 (de) 2-aminomethyl-6-sulfamoylphenolderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
ES451209A1 (es) Procedimiento de fabricacion de sulfoximidas sustituidas y sus sales medicamentosas.
ATE25523T1 (de) Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
ES463797A1 (es) Procedimiento para la preparacion de o-(2-hidroxipropil)- aldoximas sustituidas con radicales basicos
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES8604719A1 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ATE4720T1 (de) Neue derivate von cardenolid-bis-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES8600318A1 (es) Procedimiento para la obtencion de esteres de acido fosfonico
AU583267B2 (en) 9-halogen prostane derivatives
ES8104242A1 (es) Un procedimiento para la preparacion de nuevos derivados de hidantoina.
ES483298A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee